Valiant Laboratories Limited has informed the Exchange about Newspaper Advertisement for Rights issue of the company
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories Limited has published newspaper advertisements for its rights issue, in compliance with SEBI ICDR Regulations. The company is offering up to 1,08,62,500 fully paid-up equity shares of face value ₹10 each at a price of ₹75 per share (including a ₹65 premium), aggregating up to ₹8,146.88 lakhs (~₹81.47 crore). The ratio is 1 rights share for every 4 shares held, with the record date set as July 19, 2025. The issue opens on July 28, 2025, and closes on August 8, 2025, with on-market renunciation allowed until August 5, 2025. Advertisements appeared in Business Standard (English and Hindi) and Mumbai Lakshdeep (Marathi). Applications must be made through the ASBA process only, and all allotments will be in dematerialised form.
Existing shareholders as of the July 19, 2025 record date can buy additional shares at ₹75 each on a 1-for-4 basis, allowing them to maintain their ownership stake. Shareholders who do not subscribe will see their holding proportionately diluted. The company is raising up to ~₹81.47 crore, which could be used for expansion, debt reduction, or working capital needs.